The Beauty Health Company (FRA:V7A0)

The Beauty Health Company Statistics

Total Valuation

FRA:V7A0 has a market cap or net worth of EUR 163.42 million. The enterprise value is 302.41 million.

Market Cap	163.42M
Enterprise Value	302.41M

Important Dates

The next estimated earnings date is Friday, March 13, 2026.

Earnings Date	Mar 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	127.50M
Shares Outstanding	n/a
Shares Change (YoY)	+0.58%
Shares Change (QoQ)	-9.55%
Owned by Insiders (%)	9.43%
Owned by Institutions (%)	62.89%
Float	82.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	67.85
PS Ratio	0.64
PB Ratio	2.92
P/TBV Ratio	n/a
P/FCF Ratio	4.98
P/OCF Ratio	4.95
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 72.34, with an EV/FCF ratio of 9.21.

EV / Earnings	-30.21
EV / Sales	1.16
EV / EBITDA	72.34
EV / EBIT	n/a
EV / FCF	9.21

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 5.77.

Current Ratio	4.98
Quick Ratio	3.92
Debt / Equity	5.77
Debt / EBITDA	77.98
Debt / FCF	9.84
Interest Coverage	-1.82

Financial Efficiency

Return on equity (ROE) is -18.73% and return on invested capital (ROIC) is -3.28%.

Return on Equity (ROE)	-18.73%
Return on Assets (ROA)	-2.92%
Return on Invested Capital (ROIC)	-3.28%
Return on Capital Employed (ROCE)	-6.37%
Revenue Per Employee	334,621
Profits Per Employee	-13,017
Employee Count	769
Asset Turnover	0.50
Inventory Turnover	1.64

Taxes

Income Tax	-940,087
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.35% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-11.35%
50-Day Moving Average	1.28
200-Day Moving Average	1.40
Relative Strength Index (RSI)	56.35
Average Volume (20 Days)	8

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	16.61

Income Statement

In the last 12 months, FRA:V7A0 had revenue of EUR 257.32 million and -10.01 million in losses. Loss per share was -0.15.

Revenue	257.32M
Gross Profit	166.77M
Operating Income	-23.97M
Pretax Income	-10.95M
Net Income	-10.01M
EBITDA	-1.33M
EBIT	-23.97M
Loss Per Share	-0.15

Balance Sheet

The company has 185.29 million in cash and 323.00 million in debt, giving a net cash position of -137.72 million.

Cash & Cash Equivalents	185.29M
Total Debt	323.00M
Net Cash	-137.72M
Net Cash Per Share	n/a
Equity (Book Value)	55.96M
Book Value Per Share	0.44
Working Capital	210.06M

Cash Flow

In the last 12 months, operating cash flow was 33.04 million and capital expenditures -202,847, giving a free cash flow of 32.83 million.

Operating Cash Flow	33.04M
Capital Expenditures	-202,847
Free Cash Flow	32.83M
FCF Per Share	n/a

Margins

Gross margin is 64.81%, with operating and profit margins of -9.31% and -3.89%.

Gross Margin	64.81%
Operating Margin	-9.31%
Pretax Margin	-4.26%
Profit Margin	-3.89%
EBITDA Margin	-0.52%
EBIT Margin	-9.31%
FCF Margin	12.76%

Dividends & Yields

FRA:V7A0 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.58%
Shareholder Yield	-0.58%
Earnings Yield	-6.13%
FCF Yield	20.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:V7A0 has an Altman Z-Score of -0.13 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.13
Piotroski F-Score	5